Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis (Q43835283)
Jump to navigation
Jump to search
scientific article published in November 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis |
scientific article published in November 2001 |
Statements
1 reference
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis (English)
1 reference
A Zisman
1 reference
C P Ng
1 reference
A J Pantuck
1 reference
B Bonavida
1 reference
A S Belldegrun
1 reference
1 November 2001
1 reference
1 reference
Identifiers
1 reference